Akebia Therapeutics, Inc.
DE ˙ DB ˙ US00972D1054
0,83 € ↓ -0,02 (-2,69%)
2026-06-03
DEL PRIS
SecurityDE:AX9 / Akebia Therapeutics, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership238,930 shares
Latest Disclosed Value $ 384,677
Alliancebernstein L.p. ownership in AX9 / Akebia Therapeutics, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 238,930 shares of Akebia Therapeutics, Inc. (DE:AX9) valued at $272,619 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 238,930 shares of Akebia Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $198,503 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AKEBIA THREAPEUTICS COM 00972D105 238,930 0 0.00 385 0.00 0.0001
2026-02-17 2025-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 238,930 0 0.00 385 -41.10 0.0001
2025-11-14 2025-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 238,930 0 0.00 652 -24.97 0.0002
2025-08-14 2025-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 238,930 186,660 357.11 870 769.00 0.0003
2025-05-15 2025-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 52,270 -25,370 -32.68 100 -31.97 0.0000
2025-02-12 2024-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 77,640 0 0.00 148 44.12 0.0001
2024-11-14 2024-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 77,640 0 0.00 102 29.11 0.0000
2024-08-14 2024-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 77,640 77,640 79 0.0000
2022-08-15 2022-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 0 -150,335 -100.00 0 -100.00
2022-05-13 2022-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 150,335 700 0.47 108 -68.05 0.0000
2022-02-14 2021-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 149,635 0 0.00 338 -21.58 0.0001
2021-11-10 2021-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 149,635 0 0.00 431 -23.99 0.0002
2021-07-30 2021-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 149,635 82,800 123.89 567 150.88 0.0002
2021-05-06 2021-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 66,835 0 0.00 226 20.86 0.0001
2021-02-08 2020-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 66,835 -107,171 -61.59 187 -57.21 0.0001
2020-11-12 2020-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 174,006 -4,300 -2.41 437 -81.95 0.0002
2020-08-13 2020-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 178,306 55,487 45.18 2,421 160.04 0.0014
2020-05-14 2020-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 122,819 0 0.00 931 19.97 0.0007
2020-02-18 2019-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 122,819 0 0.00 776 61.33 0.0004
2019-11-14 2019-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 122,819 0 0.00 481 -19.02 0.0003
2019-08-14 2019-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 122,819 9,000 7.91 594 -36.27 0.0004
2019-05-14 2019-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 113,819 4,399 4.02 932 54.05 0.0006
2019-02-13 2018-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 109,420 57,620 111.24 605 32.39 0.0004
2018-11-08 2018-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 51,800 0 0.00 457 -11.61 0.0003
2018-08-13 2018-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 51,800 8,600 19.91 517 25.49 0.0004
2018-05-14 2018-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 43,200 0 0.00 412 -35.83 0.0003
2018-02-13 2017-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 43,200 0 0.00 642 -24.47 0.0005
2017-11-13 2017-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 43,200 0 0.00 850 36.88 0.0006
2017-08-10 2017-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 43,200 26,400 157.14 621 300.65 0.0005
2017-05-11 2017-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 16,800 0 0.00 155 -11.43 0.0001
2017-02-13 2016-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 16,800 1,600 10.53 175 26.81 0.0001
2016-11-10 2016-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 15,200 1,100 7.80 138 31.43 0.0001
2016-08-11 2016-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 14,100 14,100 0.00 105 0.0001
2015-08-14 2015-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 0 -2,300 -100.00 0 -100.00
2015-05-13 2015-03-31 13F AKEBIA THERAPEUTICS COM 00972D105 2,300 0 0.00 26 -3.70 0.0000
2015-02-13 2014-12-31 13F AKEBIA THERAPEUTICS COM 00972D105 2,300 -1,300 -36.11 27 -66.25 0.0000
2014-11-13 2014-09-30 13F AKEBIA THERAPEUTICS COM 00972D105 3,600 0 0.00 80 -20.00 0.0001
2014-08-13 2014-06-30 13F AKEBIA THERAPEUTICS COM 00972D105 3,600 3,600 100 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.